Sarah Cannon Research Institute

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Sarah Cannon Research Institute
Sep 10, 2024, 13:42 | Blog
Vivek Subbiah: A morning walk to support melanoma research
Vivek Subbiah posted on X by himself adding: "Amazing day for a morning walk to…
Sep 9, 2024, 15:30 | Societies
25 Posts Not To Miss from Day 2 of WCLC24
The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization committed…
Sep 9, 2024, 13:41 | Dialogues
Dr. Vivek Subbiah on Pioneering Precision Oncology and Global Clinical Trials | OncoInfluencers #13
Dr. Vivek Subbiah, Chief of Early Phase Drug Development at Sarah Cannon Research Institute, joins…
Sep 1, 2024, 17:03 | Blog
Vivek Subbiah: Our WHY is YOU!
Vivek Subbiah shared a post on LinkedIn: ''Clinical trials, Drug development unit dream team. Yes!…
Sep 1, 2024, 16:26 | Blog
Vivek Subbiah: Clinical trial vs fiction
Vivek Subbiah shared an article on LinkedIn: ''Every single drug, medicine, and treatment you’ve ever…
Aug 31, 2024, 09:08 | Insight
Vivek Subbiah: Our commentary on Precision oncology across the ages
Vivek Subbiah shared on LinkedIn about a recent paper titled "Precision oncology across the ages:…
Aug 29, 2024, 15:47 | Insight
Navneet Majhail: Advances and practical application of precision medicine in oncology
Navneet Majhail shared a post on LinkedIn: "On Sarah Cannon Cancer Network grand rounds today,…
Aug 26, 2024, 10:00 | Insight
Vivek Subbiah: We need to challenge Standard-of-care Paradigms in the Precision Oncology era
Vivek Subbiah shared a post on LinkedIn: "Such a delight to deliver a lecture and join…
Aug 25, 2024, 13:09 | Blog
Allison Zibelli and Erika Hamilton discussing data from the DESTINY-Breast06 and A-BRAVE trials
Sidney Kimmel Comprehensive Cancer Center at Jefferson shared a post on LinkedIn: "Dr. Allison Zibelli,…
Aug 16, 2024, 14:58 | Blog
Ishwaria Subbiah about fighting burnout on Healthcare Unfiltered with Chadi Nabhan
Chadi Nabhan, Chief Medical Officer and Head of Strategy of Ryght, shared on X: "Can…
Aug 15, 2024, 14:41 | Insight
Vivek Subbiah: Transforming the fragmented silos of medicine into a wheel of collaboration
Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared a post by…
Aug 15, 2024, 13:34 | Blog
Navneet Majhail: New complex blood cancer, HCT, and cellular therapy program at HCA Florida Healthcare North Florida
Navneet Majhail, Physician-in-Chief of Blood Cancers at Sarah Cannon Research Institute, shared a post on…
Aug 14, 2024, 07:07 | Insight
Vivek Subbiah: The evolving landscape of tissue-agnostic therapies in precision oncology
Vivek Subbiah shared on X: "Such a delight to share with in Open Access for…
Aug 14, 2024, 06:17 | Insight
Sumanta K. Pal: Viable solutions to "fragmentation" in medicine
Sumanta K. Pal shared a post by Vivek Subbiah on X: "Wonderful piece in Nature…
Aug 10, 2024, 13:38 | Insight
Vivek Subbiah: Fragmentation in medicine harms patients and hinders research
Vivek Subbiah shared on LinkedIn: "Just published in Nature Medicine: Fragmentation in medicine harms patients…
Aug 6, 2024, 16:22 | Blog
Student Early Exposure - program for students about the possibilities within the field of clinical research, writes Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Attention Students Looking for Professional Development…
Aug 5, 2024, 16:40 | Insight
Shaalan Beg: Modernizing evidence generation for regulatory approvals at ASCOBT24
Shaalan Beg, Senior Advisor for Clinical Research at the National Cancer Institute, shared a post…
Aug 4, 2024, 11:27 | Blog
Vivek Subbiah: You're all going for gold
Vivek Subbiah shared a post on LinkedIn: "Thrilled to see all our staff in the…
Aug 3, 2024, 11:42 | Blog
Ishwaria Subbiah: Privileged to present at the July 1 Rounds of the FDA Oncology Center of Excellence
Ishwaria Subbiah shared a post on LinkedIn: "That's a wrap! July 2024 took me to…
Aug 1, 2024, 15:05 | Blog
Learn about opportunities to join - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Our team members are deeply committed to…
Jul 27, 2024, 22:17 | Insight
Commentary led by Marleen Kok highlights all questions in early TNBC post-KN522
Erika Hamilton shared on X: "This commentary led by Marleen Kok highlights all the pertinent…
Jul 19, 2024, 22:55 | Blog
Potential of "smart warheads" in oncology - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: "Exciting developments in cancer treatment! Erika…
Jul 19, 2024, 08:35 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Erika Hamilton
As our next oncoinfluencer we are excited to feature Dr. Erika Hamilton, a prominent medical…
Jul 13, 2024, 12:13 | Insight
Vivek Subbiah: Great JAMA weekend read on highlights from ASCO24
Vivek Subbiah shared on LinkedIn: "Happy Friday, World! Hot off the press - published in…
Jul 12, 2024, 19:08 | Insight
Interesting study - A meta-analysis of nonrelapse mortality after CAR T cell therapy
Vivek Subbiah shared on X: "Interesting study published in NatureMedicine: A systematic review and meta-analysis…
Jul 12, 2024, 11:08 | Blog
Vivek Subbiah: How to Spend Way Less Time on Email Every Day
Vivek Subbiah shared a post on X: "How to Spend Way Less Time on Email…
Jul 5, 2024, 02:47 | Drugs
A new standard for treating limited-stage small cell lung cancer - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Dr. David R. Spigel recently shared research on durvalumab…
Jul 2, 2024, 05:00 | Insight
AlphaFold’s recent advancements and its potential impact on predictive medicine
AI in Precision Oncology  shared a post on X: "AIPO is excited to publish a…
Jul 1, 2024, 16:19 | Insight
Vivek Subbiah: Two back to back futuristic papers in the journal AI In Precision Oncology
Vivek Subbiah shared on LinkedIn: “Thrilled to have the opportunity to mentor some of the…
Jul 1, 2024, 15:15 | Blog
Cesar Perez: Increasing the Impact of Immunotherapy
Cesar Perez, Director of Drug Development at Lake Nona DDU of Florida Cancer Specialists and…
Jul 1, 2024, 14:03 | Drugs
Robert Jotte presents how Adagrasib shows improvement in PFS and ORR in previously treated patients - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Significant advancements in NSCLC treatment! SCRI's Dr. Robert Jotte…
Jul 1, 2024, 02:25 | Blog
Insights from ESMOGI24 by Cathy Eng
ESMO GI 2024 took place from June 26 to 29 in Munich, Germany, featuring both…
Jun 29, 2024, 10:28 | Blog
David R. Spigel's presentation at the 2024 ASCO on crucial developments in lung cancer treatment - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared a post on LinkedIn: “David R. Spigel, presentation at the…
Jun 29, 2024, 09:05 | Blog
Erika Hamilton: Always worth major celebration when we see survival improve by 10 months in metastatic cancer
Erika Hamilton shared a post by Healthbook on LinkedIn, adding: "Always worth major celebration when we…
Jun 28, 2024, 06:15 | Blog
The American Journal of Managed Care highlights the latest research from Erika Hamilton
Sarah Cannon Research Institute shared the following post on LinkedIn: “AJMC - The American Journal…
Jun 26, 2024, 02:20 | Insight
Brigatinib in NF2-Related Schwannomatosis
Vivek Subbiah shared on X: “Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors. NF2-related schwannomatosis (NF2-SWN,…
Jun 25, 2024, 04:14 | Blog
Dr. Meredith McKean's recent discussion on PD-1–refractory advanced melanoma at ecancer - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Dr. Meredith McKean's recent discussion on PD-1–refractory advanced melanoma…
Jun 24, 2024, 17:19 | Blog
David R. Spigel commented on the major lung cancer research updates for Patient Power
Sarah Cannon Research Institute shared on LinkedIn:                 .…
Jun 24, 2024, 15:19 | Insight
Vivek Subbiah: Precision therapy with ALK inhibitor in ALCL
Vivek Subbiah shared on X:          .  "Precision therapy with anaplastic lymphoma…
Jun 24, 2024, 13:33 | Blog
Erika Hamilton's insights into the future of ADCs in oncology - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared the following post on LinkedIn: “We are thrilled to share…
Jun 22, 2024, 15:13 | Drugs
Vivek Subbiah: Another FDA approval to adagrasib plus cetuximab for KRAS G12C-mutated colorectal cancer
Vivek Subbiah shared on LinkedIn: "It's Friday and time for another FDA approval! FDA grants…
Jun 16, 2024, 05:49 | Drugs
Vivek Subbiah: Another Tissue-Agnostic FDA approval
Vivek Subbiah shared on LinkedIn:                  . "Yes!…
Jun 15, 2024, 14:10 | Drugs
Vivek Subbiah: FDA granted full traditional approval of RET inhibitor Selpercatinib in RET+ thyroid cancers
Vivek Subbiah shared on LinkedIn:             . "FDA granted full traditional…
Jun 10, 2024, 15:27 | Blog
Cathy Eng: Join us on 6/22/2024 for ASCO24 post meeting update
Cathy Eng shared on X/Twitter: "Please join us in at Nashville 6/22/2024! For those that didn't…
Jun 10, 2024, 10:16 | Societies
It is humbling to present trials that advance care for patients to our colleagues from across the world - SCRI Oncology Partners
SCRI Oncology Partners recently shared on LinkedIn: "SCRI Oncology Partners and Sarah Cannon Research Institute…
Jun 10, 2024, 10:08 | Societies
Vivek Subbiah: I endorse Dr. Giuseppe Curigliano for ESMO President 2027-28
Vivek Subbiah shared on X: "The elections for the ESMO President 2027-2028 are happening, its…
Jun 7, 2024, 09:11 | Insight
Erika Hamilton: Happy to share the publication in Annals of Oncology
Erika Hamilton shared a post on X: “Happy to share the publication in Annals of…
Jun 7, 2024, 00:29 | Societies
Erika Hamilton: I am leaving ASCO24 filled with renewed energy and inspiration
Erika Hamilton shared a post on LinkedIn: "ASCO24 did not disappoint! So appreciative of Lynn…
Jun 5, 2024, 04:25 | Blog
Giuseppe Curigliano: Excited to see NBC News highlight the groundbreaking results of DESTINY-06
Giuseppe Curigliano reposted Erika Hamilton's post on LinkedIn, adding:    . "Excited to see NBC…
Jun 4, 2024, 16:28 | Societies
Erika Hamilton: Data that pCR translates to outcome in TNBC
Erika Hamilton shared a post on X: “PEARLY: Adriamycin Cyclophosphamide (AC) to Taxane versus AC…
Jun 3, 2024, 15:25 | Societies
15 Posts From ASCO24 Day 3 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
Jun 2, 2024, 08:53 | Blog
Erika Hamilton: Lynn Schuchter emphasizes how important communication is in oncology care
Erika Hamilton shared on LinkedIn: "ASCO president Lynn Schuchter emphasizes how important communication is in…
Jun 1, 2024, 23:04 | Societies
Vivek Subbiah: Come chat with us at the Sarah Cannon Research Institute booth
Vivek Subbiah shared on LinkedIn: "If you are at ASCO24, come say hi! Meet and…
Jun 1, 2024, 15:03 | Positive
Vivek Subbiah: This recognition is incredibly humbling and I am beyond grateful
Vivek Subbiah, recently posted on LinkedIn: "This recognition is incredibly humbling and I am beyond…
May 31, 2024, 09:57 | Career
Devon Dickey Womack: Jason Hammonds is stepping into a new role as McKesson’s Chief Operating Officer, Oncology and Specialty
Devon Dickey Womack, President of The US Oncology Network, shared on LinkedIn: "The healthcare industry…
May 29, 2024, 22:44 | Blog
Vivek Subbiah: Prepping to ASCO24 - Super Bowl for oncology
Vivek Subbiah shared on LinkedIn: "Countdown to ASCO24 Annual meeting is on! Excited for the biggest cancer…
May 26, 2024, 06:54 | Positive
Yvonne Award Winners 2024 by OncoDaily
We are excited to announce the esteemed winners of the Yvonne Award 2024 by OncoDaily, designed…
May 25, 2024, 09:42 | Societies
SCRI Oncology Partners introduces its members
Sarah Cannon Research Centre (SCRI) Oncology Partners shared on LinkedIn: With our new LinkedIn page, we…
May 25, 2024, 08:27 | Blog
Vivek Subbiah: Thank you to the OncoDaily team for the esteemed 'Voice of Oncology Award' at ASCO 2024
Vivek Subbiah shared a post by OncoDaily on LinkedIn, adding: "Gratitude overload! Sending a heartfelt…
May 24, 2024, 00:42 | Societies
Vivek Subbiah wholeheartedly supports and endorses Dr. Giuseppe Curigliano for ESMO President 2027-28
Vivek Subbiah shared on X: "Exciting news! The elections for the ESMO President 2027-2028 are…
May 22, 2024, 08:29 | Blog
Vivek Subbiah: Let's celebrate the power of research and the hope
Vivek Subbiah shared on LinkedIn: "On this Clinical Trials Day, I’m immensely grateful for the incredible…
May 19, 2024, 14:11 | Societies
20 Posts Not To Miss From ESMOBreast24!
ESMO Breast Cancer 2024 (ESMOBreast24) took place as an onsite and online event in Berlin,…
May 17, 2024, 14:50 | Insight
Erika Hamilton: Rupert Bartsch delivers a sobering reminder on brain metastasis
Erika Hamilton shared a post on X: “Rupert Bartsch delivers a sobering reminder: Although we can…
May 16, 2024, 10:07 | Blog
Melissa Johnson: Thrilled to help launch SCRI Oncology Partners’ LinkedIn page!
Melissa Johnson, Director of Lung Cancer Research at Sarah Cannon, shared a post by SCRI…
May 16, 2024, 10:02 | Blog
Updated Breast Cancer Screening Recommendation - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Updated Breast Cancer Screening Recommendation. SCRI breast cancer…
May 13, 2024, 12:27 | Insight
Vivek Subbiah: Interpreting and integrating genomic tests results in clinical cancer care
Vivek Subbiah shared on X: "Published now in the May/ June issue 2024 at CA:…
May 13, 2024, 07:59 | Blog
Erika Hamilton: Check out our new practice LinkedIn page
Erika Hamilton shared a post by SCRI Oncology Partners on LinkedIn, adding: ''Check out our new practice…
May 9, 2024, 11:35 | Insight
Vivek Subbiah: SERENA-1 monotherapy results in Annals of Oncology
Quoting Vivek Subbiah on X: . "A Phase 1 dose escalation and expansion trial of…
May 9, 2024, 11:00 | Insight
Vivek Subbiah: AlphaFold 3 is beyond amazing!
Vivek Subbiah shared on X: “Wow! Just when we thought Alphafold 1,2 are groundbreaking, it’s…
May 8, 2024, 10:41 | Blog
Erika Hamilton: An update from the previous 2016 guideline and a couple highlights
Erika Hamilton shared a post on LinkedIn: "Thanks to News Nation and Nichole Berlie for having…
May 6, 2024, 08:10 | Blog
Vivek Subbiah: A goosebumps moment
Vivek Subbiah shared on X/Twitter: "A goosebumps moment and an example of what an amazing…
May 5, 2024, 00:31 | Blog
Erika Hamilton: Thanks for having me on USPTF updated breast screening recommendations
Erika Hamilton shared on LinkedIn: “Thanks to News Nation and Nichole Berlie for having me…
May 2, 2024, 14:25 | Insight
Fabrice Andre: A nice seminar around Precision Medicine
Vivek Subbiah shared a post by Fabrice Andre, Head of Research Division at Gustave Roussy…
May 2, 2024, 02:08 | Blog
Variant allele frequency by Vivek Subbiah
Vivek Subbiah shared on X: "Variant allele frequency: a decision-making tool in precision oncology? Trends…
Apr 30, 2024, 05:44 | Blog
Ishwaria Subbiah: FTC Announces Rule Banning Non-competes
Ishwaria Subbiah shared a post on X: "Wow. FTC (Federal Trade Commission) Announces Rule Banning…
Apr 29, 2024, 20:00 | Opinion
Erika Hamilton: Really feel like we don't need to be testing for HER-2 for TDXd in breast cancer
Erika Hamilton shared a post by Giuseppe Curigliano, Chief of the Clinical Division of Early…
Apr 26, 2024, 12:00 | Blog
Vivek Subbiah: Window of opportunity (WOO) studies across cancer subtypes by Barbara Pistilli
Vivek Subbiah shared a post on X/Twitter: "Window of opportunity (WOO) studies across cancer subtypes?…
Apr 26, 2024, 11:10 | Blog
Vivek Subbiah: The world of oncology converges in Zurich, Switzerland!
Vivek Subbiah posted on X/Twitter: ''The world of oncology converges in Zurich, Switzerland! Such an…
Apr 26, 2024, 09:41 | Blog
Vivek Subbiah: Read a recap of 'AI at the Interface' at AACR24 plenary session in AACR Annual Meeting News
Vivek Subbiah posted on X/Twitter: ''Yes! The future IS now! 'AI at the Interface: Accelerating…
Apr 25, 2024, 20:18 | Positive
Vivek Subbiah: HUGE MILESTONE in all of medicine and a huge win for patients and families with sickle cell disease and β-Thalassemia
Quoting Vivek Subbiah's post on X/Twitter: "Hot off the press! HUGE MILESTONE in all of…
Apr 24, 2024, 12:07 | Blog
Vivek Subbiah: One mission = Eradicate cancer
Vivek Subbiah shared on Twitter/X: "One of the greatest advantages of in person scientific meetings is…
Apr 23, 2024, 16:35 | Blog
Stephanie Graff: Sheila Johnson is a force—I hope to carry her energy and spirit in all that I do
Stephanie Graff shared a post by Erika Hamilton on X and added: "Sheila Johnson is…
Apr 23, 2024, 12:12 | Societies
Vivek Subbiah: Fantastic overview of Molecular Tumor Boards - MTB 101 and in-depth thought-provoking lecture by the amazing Ben Westphalen
Vivek Subbiah shared a post on X: "Fantastic overview of Molecular Tumor Boards - MTB…
Apr 23, 2024, 11:34 | Blog
Vivek Subbiah: What a beautiful venue for a terrific meeting - the Italian Summit of Precision Oncology
Vivek Subbiah shared a post on X: "American Academy of Rome! What a beautiful venue…
Apr 23, 2024, 11:10 | Blog
Ishwaria Subbiah: Whether it's access to clinical trials or palliative care, cancer challenges are global, and so are our collaborations!
Ishwaria Subbiah recently shared on LinkedIn: "To Brazil from New Orleans in just a weekend!…
Apr 20, 2024, 05:32 | Blog
Navneet Majhail: Congratulations to the EBMT for 50 years of supporting international transplant and cellular therapy community
Navneet Majhail, Physician-in-Chief of Blood Cancers at Sarah Cannon Research Institute, shared on X: "Congratulations…
Apr 19, 2024, 20:37 | Societies
Vivek Subbiah: 4th ESMO webinar of the Precision Oncology series
Vivek Subbiah shared a post by Diogo Martins Branco, Board Member at AICSO, on X/Twitter,…
Apr 15, 2024, 21:22 | Blog
Michelyn Smith: Let's spread awareness about clinical trials
Michelyn Smith, Head of Talent Acquisition at Sarah Cannon Research Institute, shared a post by Vivek…
Apr 14, 2024, 22:37 | Insight
Vivek Subbiah: Prostate cancer cases are projected to double to 2.9 million per year by 2040
Quoting Vivek Subbiah's post on X/Twitter: "Prostate cancer cases are projected to double to 2.9…
Apr 14, 2024, 12:08 | Blog
Vivek Subbiah: Talk about shaking the field of cancer research- cracking KRAS
Vivek Subbiah shared a post on LinkedIn: ''Talk about shaking the field of cancer research- cracking…
Apr 14, 2024, 03:32 | Career
Vivek Subbiah: Sending massive congratulations to the incredible Patricia M. LoRusso for her Presidency at the American Association for Cancer Research!
Vivek Subbiah shared a post on X/Twitter: "Sending massive congratulations to the incredible AACR President,…
Apr 14, 2024, 03:08 | Societies
Vivek Subbiah: The future of cancer research shines brightly!
Quoting Vivek Subbiah on X/Twitter: "The future of cancer research shines brightly! It was an honor…
Apr 14, 2024, 02:26 | Insight
Vivek Subbiah: A pan-cancer analysis of the microbiome in metastatic cancer
Quoting Vivek Subbiah on X/Twitter: "A pan-cancer analysis of the microbiome in metastatic cancer: Cell.…
Apr 12, 2024, 16:21 | Societies
Vivek Subbiah: Where does the AACR24 Plenary Chair work with the ASCO Plenary Chair?
Vivek Subbiah shared a post on LinkedIn: "Where does the American Association for Cancer Research AACR24 Plenary…
Apr 11, 2024, 06:54 | Blog
Vivek Subbiah: Watching the celestial event at the AACR24 brings everyone together
Vivek Subbiah shared a post on X: "Wow! Watching the celestial event at the AACR24 brings…
Apr 10, 2024, 09:21 | Blog
Vivek Subbiah: Future of cancer research is bright!
Vivek Subbiah shared on X/Twitter: "Future of cancer research is bright! So nice to see…
Apr 10, 2024, 09:09 | Blog
Vivek Subbiah: Super delighted to meet the amazing Elizabeth McKenna, Executive Editor of Cancer Discovery
Vivek Subbiah shared on X/Twitter: "Super delighted to meet the amazing Elizabeth McKenna, Executive Editor…
Apr 10, 2024, 06:07 | Blog
Vivek Subbiah: Such a delight to meet with the terrific Arul Chinnayan at AACR24
Vivek Subbiah recently shared on his X/Twitter: ''Such a delight to meet with the terrific…
Apr 9, 2024, 16:59 | Positive
Erika Hamilton: This is the power of clinical trials!
Erika Hamilton shared a post by Mel Mann, a Patient Advocate for Oncology, Health Equity,…
Apr 9, 2024, 13:58 | Blog
Vivek Subbiah: Profiling tumor ecosystems in native tissue context
Vivek Subbiah recently shared on his X/Twitter: ''Profiling tumor ecosystems in native tissue context: Michael…
12
All: 164 Posts: 1 - 100
Special Coverage